La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.

Identifieur interne : 000614 ( PubMed/Checkpoint ); précédent : 000613; suivant : 000615

Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.

Auteurs : Leigh Christopher [Canada] ; Yuko Koshimori [Canada] ; Anthony E. Lang [Canada] ; Marion Criaud [Canada] ; Antonio P. Strafella [Canada]

Source :

RBID : pubmed:24736308

English descriptors

Abstract

Patients with Parkinson's disease experience a range of non-motor symptoms, including cognitive impairment, behavioural changes, somatosensory and autonomic disturbances. The insula, which was once thought to be primarily a limbic cortical structure, is now known to be highly involved in integrating somatosensory, autonomic and cognitive-affective information to guide behaviour. Thus, it acts as a central hub for processing relevant information related to the state of the body as well as cognitive and mood states. Despite these crucial functions, the insula has been largely overlooked as a potential key region in contributing to non-motor symptoms of Parkinson's disease. The insula is affected in Parkinson's disease by alpha-synuclein deposition, disruptions in normal neurotransmitter function, alterations in connectivity as well as metabolic and structural changes. Although research focusing on the role of the insula in Parkinson's disease is scarce, there is evidence from neuroimaging studies linking the insula to cognitive decline, behavioural abnormalities and somatosensory disturbances. Here, we review imaging studies that provide insight into the potential role of the insula in Parkinson's disease non-motor symptoms.

DOI: 10.1093/brain/awu084
PubMed: 24736308


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24736308

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.</title>
<author>
<name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koshimori, Yuko" sort="Koshimori, Yuko" uniqKey="Koshimori Y" first="Yuko" last="Koshimori">Yuko Koshimori</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Criaud, Marion" sort="Criaud, Marion" uniqKey="Criaud M" first="Marion" last="Criaud">Marion Criaud</name>
<affiliation wicri:level="4">
<nlm:affiliation>2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada antonio.strafella@uhnres.utoronto.ca antonio.strafella@camhpet.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24736308</idno>
<idno type="pmid">24736308</idno>
<idno type="doi">10.1093/brain/awu084</idno>
<idno type="wicri:Area/PubMed/Corpus">000700</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000700</idno>
<idno type="wicri:Area/PubMed/Curation">000700</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000700</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000700</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000700</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.</title>
<author>
<name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koshimori, Yuko" sort="Koshimori, Yuko" uniqKey="Koshimori Y" first="Yuko" last="Koshimori">Yuko Koshimori</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Criaud, Marion" sort="Criaud, Marion" uniqKey="Criaud M" first="Marion" last="Criaud">Marion Criaud</name>
<affiliation wicri:level="4">
<nlm:affiliation>2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name>
<affiliation wicri:level="4">
<nlm:affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada antonio.strafella@uhnres.utoronto.ca antonio.strafella@camhpet.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Brain : a journal of neurology</title>
<idno type="eISSN">1460-2156</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cerebral Cortex (metabolism)</term>
<term>Cerebral Cortex (physiopathology)</term>
<term>Humans</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (physiopathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cerebral Cortex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Cerebral Cortex</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Patients with Parkinson's disease experience a range of non-motor symptoms, including cognitive impairment, behavioural changes, somatosensory and autonomic disturbances. The insula, which was once thought to be primarily a limbic cortical structure, is now known to be highly involved in integrating somatosensory, autonomic and cognitive-affective information to guide behaviour. Thus, it acts as a central hub for processing relevant information related to the state of the body as well as cognitive and mood states. Despite these crucial functions, the insula has been largely overlooked as a potential key region in contributing to non-motor symptoms of Parkinson's disease. The insula is affected in Parkinson's disease by alpha-synuclein deposition, disruptions in normal neurotransmitter function, alterations in connectivity as well as metabolic and structural changes. Although research focusing on the role of the insula in Parkinson's disease is scarce, there is evidence from neuroimaging studies linking the insula to cognitive decline, behavioural abnormalities and somatosensory disturbances. Here, we review imaging studies that provide insight into the potential role of the insula in Parkinson's disease non-motor symptoms.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24736308</PMID>
<DateCreated>
<Year>2014</Year>
<Month>07</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>2143-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu084</ELocationID>
<Abstract>
<AbstractText>Patients with Parkinson's disease experience a range of non-motor symptoms, including cognitive impairment, behavioural changes, somatosensory and autonomic disturbances. The insula, which was once thought to be primarily a limbic cortical structure, is now known to be highly involved in integrating somatosensory, autonomic and cognitive-affective information to guide behaviour. Thus, it acts as a central hub for processing relevant information related to the state of the body as well as cognitive and mood states. Despite these crucial functions, the insula has been largely overlooked as a potential key region in contributing to non-motor symptoms of Parkinson's disease. The insula is affected in Parkinson's disease by alpha-synuclein deposition, disruptions in normal neurotransmitter function, alterations in connectivity as well as metabolic and structural changes. Although research focusing on the role of the insula in Parkinson's disease is scarce, there is evidence from neuroimaging studies linking the insula to cognitive decline, behavioural abnormalities and somatosensory disturbances. Here, we review imaging studies that provide insight into the potential role of the insula in Parkinson's disease non-motor symptoms.</AbstractText>
<CopyrightInformation>© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Christopher</LastName>
<ForeName>Leigh</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koshimori</LastName>
<ForeName>Yuko</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lang</LastName>
<ForeName>Anthony E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Criaud</LastName>
<ForeName>Marion</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strafella</LastName>
<ForeName>Antonio P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>1 Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada2 Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada3 Research Institute, UHN, University of Toronto, Ontario, Canada antonio.strafella@uhnres.utoronto.ca antonio.strafella@camhpet.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>110962-1</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID>MOP 110962</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 1997 Apr;54(4):450-4</RefSource>
<PMID Version="1">9109747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosomatics. 2010 Jan-Feb;51(1):22-8</RefSource>
<PMID Version="1">20118437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Neurol. 1997;38 Suppl 2:2-7</RefSource>
<PMID Version="1">9387796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2009 Jan;10(1):59-70</RefSource>
<PMID Version="1">19096369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 2011 Sep;32(9):1443-57</RefSource>
<PMID Version="1">20740649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):636-42</RefSource>
<PMID Version="1">12438462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2013 Mar;136(Pt 3):790-803</RefSource>
<PMID Version="1">23423672</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):138-42</RefSource>
<PMID Version="1">1538221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Auton Res. 2005 Apr;15(2):76-82</RefSource>
<PMID Version="1">15834763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2005 Sep 19;490(2):101-18</RefSource>
<PMID Version="1">16052493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Affect Disord. 2011 Sep;133(1-2):120-7</RefSource>
<PMID Version="1">21531027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Sep 11;79(11):1155-60</RefSource>
<PMID Version="1">22895582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Nov;133(11):3434-43</RefSource>
<PMID Version="1">20884645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2012 Jun;46(3):572-80</RefSource>
<PMID Version="1">22094370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2002 Mar;15(3):596-603</RefSource>
<PMID Version="1">11848702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2005 Dec;20(12):1557-63</RefSource>
<PMID Version="1">16078219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Feb 15;22(3):297-308</RefSource>
<PMID Version="1">17133511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2003 Aug;19(4):1439-48</RefSource>
<PMID Version="1">12948701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Nov 21;32(47):16683-92</RefSource>
<PMID Version="1">23175822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2013 Jan 1;73(1):85-92</RefSource>
<PMID Version="1">22770651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Biobehav Rev. 2009 Sep;33(8):1198-203</RefSource>
<PMID Version="1">19538989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schizophr Res. 2010 Nov;123(2-3):105-15</RefSource>
<PMID Version="1">20724114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 May;132(Pt 5):1376-85</RefSource>
<PMID Version="1">19346328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2013 Mar;23(3):739-49</RefSource>
<PMID Version="1">22437053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2011 Mar 1;55(1):8-23</RefSource>
<PMID Version="1">21111053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2005 Dec 5;493(1):154-66</RefSource>
<PMID Version="1">16254997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Senses. 2005 Sep;30(7):583-92</RefSource>
<PMID Version="1">16135744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2002 Mar;8(4):277-84</RefSource>
<PMID Version="1">12039423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2007 Jul;13(5):308-11</RefSource>
<PMID Version="1">16962365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46</RefSource>
<PMID Version="1">9153598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Dec;21(12):2042-51</RefSource>
<PMID Version="1">17078043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Parkinsons Dis. 2013;3(2):105-38</RefSource>
<PMID Version="1">23938342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsons Dis. 2012;2012:198316</RefSource>
<PMID Version="1">22888466</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Dec;60(6):660-7</RefSource>
<PMID Version="1">17187353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2012 Dec;48(3):519-25</RefSource>
<PMID Version="1">22766031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Hum Neurosci. 2013 Feb 04;7:14</RefSource>
<PMID Version="1">23382714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Bull. 2006 Dec 11;71(1-3):259-69</RefSource>
<PMID Version="1">17113955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Soc Cogn Affect Neurosci. 2014 Jun;9(6):857-63</RefSource>
<PMID Version="1">23596189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2013 Aug;136(Pt 8):2539-49</RefSource>
<PMID Version="1">23824490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2006 Mar;129(Pt 3):707-17</RefSource>
<PMID Version="1">16415306</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2003 Oct;18(7):2059-68</RefSource>
<PMID Version="1">14622239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1984 Jul;34(7):957-9</RefSource>
<PMID Version="1">6539873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Jan;27(1):84-9</RefSource>
<PMID Version="1">21994070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hum Evol. 2013 Apr;64(4):263-79</RefSource>
<PMID Version="1">23466178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2002 Feb 14;33(4):653-63</RefSource>
<PMID Version="1">11856537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2000 Nov;3(11):1077-8</RefSource>
<PMID Version="1">11036262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1997 Dec 15;17(24):9686-705</RefSource>
<PMID Version="1">9391023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2007 Jan;130(Pt 1):233-44</RefSource>
<PMID Version="1">17121746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2014 Feb;29(2):214-20</RefSource>
<PMID Version="1">24123483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2004 Nov;19(11):1348-51</RefSource>
<PMID Version="1">15389994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2012;195:123-63</RefSource>
<PMID Version="1">22230626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):216-9</RefSource>
<PMID Version="1">19622693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1984 Jul 20;227(1):109-20</RefSource>
<PMID Version="1">6470205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Soc Neurosci. 2009;4(4):347-58</RefSource>
<PMID Version="1">19466680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychopharmacology. 2009 Dec;34(13):2758-66</RefSource>
<PMID Version="1">19741594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2009 Aug;256 Suppl 3:293-8</RefSource>
<PMID Version="1">19711119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Struct Funct. 2010 Jun;214(5-6):495-517</RefSource>
<PMID Version="1">20512377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Feb 1;26(2):225-33</RefSource>
<PMID Version="1">21284039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 1996 Oct 29;351(1346):1413-20</RefSource>
<PMID Version="1">8941953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Feb 28;27(9):2349-56</RefSource>
<PMID Version="1">17329432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Auton Res. 2012 Feb;22(1):57-61</RefSource>
<PMID Version="1">21796351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA Psychiatry. 2013 Aug;70(8):821-9</RefSource>
<PMID Version="1">23760393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Struct Funct. 2010 Jun;214(5-6):465-75</RefSource>
<PMID Version="1">20512369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Neurosci. 2013 Apr;127(2):184-92</RefSource>
<PMID Version="1">23067384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Jun 19;33(25):10503-11</RefSource>
<PMID Version="1">23785162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2002 Aug;3(8):655-66</RefSource>
<PMID Version="1">12154366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1982 Nov 20;212(1):1-22</RefSource>
<PMID Version="1">7174905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1990 Apr;27(4):373-85</RefSource>
<PMID Version="1">1972319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 1994;88(6):493-500</RefSource>
<PMID Version="1">7879596</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Mar;27(3):349-56</RefSource>
<PMID Version="1">22275317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Jul 15;22(9):1272-7</RefSource>
<PMID Version="1">17415797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1982 Nov 20;212(1):38-52</RefSource>
<PMID Version="1">7174907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2000 Feb 15;523 Pt 1:259-70</RefSource>
<PMID Version="1">10673560</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2012 Oct 15;63(1):320-7</RefSource>
<PMID Version="1">22776459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2009 Aug;13(8):334-40</RefSource>
<PMID Version="1">19643659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2004 Jan 21;24(3):702-10</RefSource>
<PMID Version="1">14736856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 1999 Jul;122 ( Pt 7):1271-82</RefSource>
<PMID Version="1">10388793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2009 May;8(5):464-74</RefSource>
<PMID Version="1">19375664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Dec 1;30(48):16324-31</RefSource>
<PMID Version="1">21123578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 2014 May;35(5):2206-19</RefSource>
<PMID Version="1">23760982</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2014 Feb;137(Pt 2):565-75</RefSource>
<PMID Version="1">24334314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Struct Funct. 2010 Jun;214(5-6):655-67</RefSource>
<PMID Version="1">20512370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Oct 30;25(14):2318-25</RefSource>
<PMID Version="1">20669264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 1997 Jan-Feb;7(1):86-95</RefSource>
<PMID Version="1">9023436</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">CAMS4601</OtherID>
<OtherID Source="NLM">PMC4107733</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
<Keyword MajorTopicYN="N">behaviour</Keyword>
<Keyword MajorTopicYN="N">cognition</Keyword>
<Keyword MajorTopicYN="N">insula</Keyword>
<Keyword MajorTopicYN="N">neuroimaging</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24736308</ArticleId>
<ArticleId IdType="pii">awu084</ArticleId>
<ArticleId IdType="doi">10.1093/brain/awu084</ArticleId>
<ArticleId IdType="pmc">PMC4107733</ArticleId>
<ArticleId IdType="mid">CAMS4601</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Ontario">
<name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name>
</region>
<name sortKey="Criaud, Marion" sort="Criaud, Marion" uniqKey="Criaud M" first="Marion" last="Criaud">Marion Criaud</name>
<name sortKey="Koshimori, Yuko" sort="Koshimori, Yuko" uniqKey="Koshimori Y" first="Yuko" last="Koshimori">Yuko Koshimori</name>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000614 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000614 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24736308
   |texte=   Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24736308" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022